Cargando…
Growth hormone treatment and risk of malignancy
Growth hormone (GH) treatment has been increasingly widely used for children with GH deficiencies as the survival rate of pediatric patients with malignancies has increased. Both GH and insulin-like growth factor-I have mitogenic and antiapoptotic activity, prompting concern that GH treatment may be...
Autores principales: | Chae, Hyun-Wook, Kim, Duk-Hee, Kim, Ho-Seong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Pediatric Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357770/ https://www.ncbi.nlm.nih.gov/pubmed/25774194 http://dx.doi.org/10.3345/kjp.2015.58.2.41 |
Ejemplares similares
-
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014) -
Sex hormone binding globulin, free estradiol index, and lipid profiles in girls with precocious puberty
por: Chae, Hyun-Wook, et al.
Publicado: (2013) -
Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats
por: Lee, Junghun, et al.
Publicado: (2018) -
Male patients presenting with rapidly progressive puberty associated with malignant tumors
por: Kim, Soo Jung, et al.
Publicado: (2016) -
Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study
por: Rhie, Young-Jun, et al.
Publicado: (2019)